AAA
ABBV icon

AG Asset Advisory’s AbbVie ABBV Stock Holding History

AG Asset Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Hold
1,130
– – 0.2% 25
2025
Q4 		$258K Hold
1,130
– – 0.22% 24
2025
Q3 		$262K Hold
1,130
– – 0.22% 24
2025
Q2 		$210K Hold
1,130
– – 0.18% 21
2025
Q1 		$237K Hold
1,130
– – 0.24% 22
2024
Q4 		$201K Buy
+1,130
New +$208K 0.2% 23

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AG Asset Advisory's ABBV Position: Q1 2026 in Review

AG Asset Advisory held its AbbVie (ABBV) position steady in Q1 2026 at 1,130 shares worth $246K. The position accounts for 0.2% of the portfolio, ranked #25.

AG Asset Advisory first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $262K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • AG Asset Advisory held 1,130 shares of AbbVie worth $246K as of Q1 2026.
  • AG Asset Advisory left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.2% of AG Asset Advisory's portfolio in Q1 2026, its #25 holding.
  • AG Asset Advisory first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • AG Asset Advisory's AbbVie position peaked at $262K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AG Asset Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.